Alexandria Real Estate Equities heads into its third-quarter report with an unusual split between what management said and what the market has done. Last quarter's call had a clearly improving tone, with leasing up 60% from the first quarter, more tenants in the market and free rent concessions easing. Yet the stock has fallen nearly 20% since then while the S&P 500 was roughly flat. The report due after the close on October 26 has to show whether the operating recovery is real enough to outweigh asset sales running late and impairments that may not be finished.
The bar is set low on the surface. Analysts expect $1.52 per share, down 31.5% from $2.22 a year ago and well below last quarter's $1.73. Revenue is forecast at $644.2 million, a 14.3% decline year over year and a step down from $662.8 million in the second quarter. This is a business still contracting as occupancy slips, dispositions shrink the asset base and capitalized interest falls. The Earnings Whisper matches consensus at $1.52, so there is no hidden optimism in the number. Management narrowed full-year FFO guidance to $6.35 to $6.45 per share, and the Street's $6.36 sits near the bottom of that range. That positioning matters because management has already said fourth-quarter FFO will likely land at the low end of $1.40 to $1.50. Analysts are not betting on any upside, and Alexandria's history of cutting targets, including a $0.25 reduction to 2025 FFO a year ago, explains why.
Leasing volume is the first test. Management pointed to roughly 950,000 square feet for the third quarter. Hitting or beating that after the 1.04 million square feet in the second quarter would show the rebound was not a single good quarter. Investors should also look at the mix. Advanced-technology tenants made up about 30% of second-quarter volume, needing less capital for comparable returns, and public biotech came back to 5.8% of volume from zero. Further progress at 311 Arsenal, where letters of intent could take the building to 44% leased, and steady terms on concessions would support the view that demand in the middle of the market, the 20,000 to 100,000 square foot range, is coming back.
The risks are mostly about balance sheet and timing. Dispositions slipped about six weeks to a September weighted average, partly because joint ventures are complicated and buyers of non-core assets have struggled to arrange financing. Confirmation that those sales closed is essential for funding a 2027 construction budget that has risen to $1.15 billion to $1.65 billion. After $222.5 million of impairments in the second quarter, management warned more could follow. Occupancy, which was 86.9% against an 87% full-year midpoint, has almost no room to fall further. Meanwhile, 1.4 million square feet of key 2027 expirations now carry expected downtime of 12 to 24 months, so any early news on backfilling that space would be valuable.
Sentiment has improved slightly, with bearish readings easing to 46.1% from 49.9% before the last report, but the stock has been hit hard. At $41.62, shares sit just above the post-earnings low of $41.02 and about 17% below the 200-day moving average near $50. The prior quarter's low of $39.41 is the next reference point if the news disappoints.
In the end, the report hinges on whether Alexandria can turn improving leasing activity into steady occupancy while getting its asset sales done. Strong leasing, completed dispositions and a reaffirmed guidance range would support management's recovery story. More impairments, further delays or pressure on the low end of guidance would suggest the selloff was justified.